Logo image of SYNH

SYNEOS HEALTH INC (SYNH) Stock Analyst Ratings

NASDAQ:SYNH - Nasdaq - US87166B1026 - Common Stock - Currency: USD

42.98  +0.01 (+0.02%)

After market: 42.97 -0.01 (-0.02%)

Buy % Consensus

54

ChartMill assigns a Buy % Consensus number of 54% to SYNH. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 43.35. This target is 0.86% above the current price.
SYNH was analyzed by 16 analysts. The buy percentage consensus is at 54. So analysts seem to be rather neutral about SYNH.
In the previous month the buy percentage consensus was at a similar level.
SYNH was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
SYNH Historical Analyst RatingsSYNH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -81 -73 -65 -57 -49 -41 -33 -25 -17 -9 -1 5 10 15

Price Target & Forecast

Price Low Median Mean High 42.9840.4043.8643.3545.15 - -6.00% 2.05% 0.86% 5.05%
SYNH Current Analyst RatingSYNH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2023-05-16 Mizuho Maintains Neutral -> Neutral
2023-05-11 Deutsche Bank Downgrade Buy -> Hold
2023-05-11 Barclays Upgrade Underweight -> Equal-Weight
2023-05-11 Baird Downgrade Outperform -> Neutral
2023-04-04 Barclays Maintains Underweight
2023-03-01 Barclays Maintains Underweight
2023-02-17 Mizuho Reiterate Neutral
2023-02-17 Baird Maintains Outperform
2023-02-13 JP Morgan Downgrade Neutral -> Underweight
2023-01-17 Barclays Downgrade Overweight -> Underweight
2023-01-13 Barclays Downgrade Overweight -> Underweight
2022-12-14 Mizuho Downgrade Buy -> Neutral
2022-11-07 Barclays Maintains Overweight
2022-11-07 Baird Maintains Outperform
2022-11-07 Citigroup Maintains Neutral
2022-10-18 JP Morgan Downgrade Overweight -> Neutral
2022-10-12 Mizuho Maintains Buy
2022-10-12 Deutsche Bank Maintains Buy
2022-10-06 Barclays Maintains Overweight
2022-10-05 Citigroup Maintains Neutral
2022-09-16 Baird Maintains Outperform
2022-09-14 Guggenheim Downgrade Buy -> Neutral
2022-09-12 Barclays Maintains Overweight
2022-09-07 UBS Initiate Neutral
2022-08-03 Mizuho Maintains Buy
2022-07-13 Barclays Maintains Overweight
2022-05-24 Guggenheim Initiate Buy
2022-04-25 Jefferies Downgrade Buy -> Hold
2022-04-12 Deutsche Bank Initiate Buy
2022-03-07 Mizuho Maintains Buy